Literature DB >> 17571270

[The primary objective in macular hole surgery. Ultrastructural features of the vitreomacular interface].

R G Schumann1, M M Schaumberger, M Rohleder, C Haritoglou, A Kampik, A Gandorfer.   

Abstract

We compared the ultrastructure of the inner limiting membrane (ILM) and epiretinal tissue in closed and non-closed, idiopathic macular holes (MH). Peeling of ILM and epimacular tissue during vitrectomy was successfully performed on 77 eyes with stage III MH and on 19 eyes with stage IV MH. In 16 additional eyes with non-closed MH, we performed a second vitrectomy with extended ILM removal. The specimens were processed for transmission electron microscopy. Fibrocellular proliferation at the vitreal side of the ILM was found in 57% of MH that were closed by one operation, and in 100% of non-closed MH. Mono- and multilayered cellular membranes as well as native vitreous collagen at the ILM were significantly more frequent in eyes with stage IV MH than in eyes with stage III MH. In non-closed MH, cellular proliferation was mostly seen as irregular cell accumulation, and masses of newly formed collagen were found. Since ILM remnants and collagen represent a stimulus for the early formation of tangential traction preventing successful MH closure, it appears mandatory to create a complete vitreoretinal separation and to remove the ILM and collagen thoroughly during MH surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571270     DOI: 10.1007/s00347-007-1553-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  27 in total

1.  Perifoveal vitreous detachment is the primary pathogenic event in idiopathic macular hole formation.

Authors:  M W Johnson; M R Van Newkirk; K A Meyer
Journal:  Arch Ophthalmol       Date:  2001-02

2.  Point: to peel or not to peel, that is the question.

Authors:  Ferenc Kuhn
Journal:  Ophthalmology       Date:  2002-01       Impact factor: 12.079

3.  Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction.

Authors:  Arnd Gandorfer; Matthias Rohleder; Sabine Grosselfinger; Christos Haritoglou; Michael Ulbig; Anselm Kampik
Journal:  Am J Ophthalmol       Date:  2005-04       Impact factor: 5.258

4.  Epiretinal membrane surgery with or without internal limiting membrane peeling.

Authors:  Alvin Kh Kwok; Timothy Yy Lai; Kenneth Sc Yuen
Journal:  Clin Exp Ophthalmol       Date:  2005-08       Impact factor: 4.207

5.  Ultrastructural features of tissue removed during idiopathic macular hole surgery.

Authors:  H S Yooh; H L Brooks; A Capone; N L L'Hernault; H E Grossniklaus
Journal:  Am J Ophthalmol       Date:  1996-07       Impact factor: 5.258

6.  Clinicopathologic correlation of an epiretinal membrane associated with a recurrent macular hole.

Authors:  S Fekrat; R T Wendel; Z de la Cruz; W R Green
Journal:  Retina       Date:  1995       Impact factor: 4.256

7.  Long-term follow-up after macular hole surgery with internal limiting membrane peeling.

Authors:  Christos Haritoglou; Carolin A Gass; Markus Schaumberger; Arnd Gandorfer; Michael W Ulbig; Anselm Kampik
Journal:  Am J Ophthalmol       Date:  2002-11       Impact factor: 5.258

8.  Long-term anatomic and visual acuity outcomes after initial anatomic success with macular hole surgery.

Authors:  Ingrid U Scott; Alexei L Moraczewski; William E Smiddy; Harry W Flynn; William J Feuer
Journal:  Am J Ophthalmol       Date:  2003-05       Impact factor: 5.258

9.  Long-term incidence of reopening of macular holes.

Authors:  M Paques; P Massin; P Blain; A S Duquesnoy; A Gaudric
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

10.  Posterior vitreous detachment and macular hole formation in myopic foveoschisis.

Authors:  Nagakazu Matsumura; Yasushi Ikuno; Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2004-12       Impact factor: 5.258

View more
  1 in total

1.  Incidence and prevalence of vitreomacular traction with and without macular hole in Germany.

Authors:  Jacob Menzler; Aljoscha Steffen Neubauer; Christos Haritoglou; Timothy L Jackson
Journal:  Clin Ophthalmol       Date:  2019-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.